Evidence map›Paper›PMID 31900176›Full record

ArticleOrphanet journal of rare diseases2020

The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers.

Anna L Bruckner, Michael Losow, Jayson Wisk, Nita Patel, Allen Reha, Hjalmar Lagast, Jamie Gault, Jayne Gershkowitz, Brett Kopelan, Michael Hund and 1 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 2 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 2 syntheses or guidelines pooled it, 182 citations in OpenAlex.

  1. Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Health-Related Quality of Life of Patients withJournal of market access & health policy · 2026
    Article
  9. Article
  10. Eliciting health state utilities for open wounds in dystrophic epidermolysis bullosa.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Anna L BrucknerChildren's Hospital Colorado, University of Colorado School of Medicine, 13123 E 16th Ave, B570, Aurora, CO, 80045, USA. anna.bruckner@cuanschutz.edu.
Michael LosowAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Jayson WiskAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Nita PatelAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Allen RehaAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Hjalmar LagastAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Jamie GaultAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Jayne GershkowitzAmicus Therapeutics, Inc, 1 Cedar Brook Drive, Cranbury, NJ, 08512, USA.
Brett KopelanDebra of America, 75 Broad St #300, New York, NY, 10004, USA.
Michael HundEB Research Partnership, 132 East 43rd St, Suite 432, New York, NY, 10017, USA.
Dedee F MurrellSt. George-Hospital, University of Sydney, NSW, 2052, Australia.
Amicus Therapeutics (United States) · USChildren's Hospital Colorado · USDystrophic Epidermolysis Bullosa Research Association of America · USSt George Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle information is available regarding the burden of living with and managing epidermolysis bullosa, including the distinct challenges faced by patients with different disease types/subtypes.

methodsA 90-question/item survey was developed to collect demographics, diagnostic data, management practices, and burden of illness information for patients with epidermolysis bullosa living in the United States. Recruitment was conducted via email and social media in partnership with epidermolysis bullosa patient advocacy organizations in the United States, and the survey was conducted via telephone interview by a third-party health research firm. Respondents aged ≥ 18 years with a confirmed diagnosis of epidermolysis bullosa or caring for a patient with a confirmed diagnosis of epidermolysis bullosa were eligible to participate in the survey.

resultsIn total, 156 responses were received from patients (n = 63) and caregivers (n = 93) representing the epidermolysis bullosa types of simplex, junctional, and dystrophic (subtypes: dominant and recessive). A large proportion of patients (21%) and caregivers (32%) reported that the condition was severe or very severe, and 19% of patients and 26% of caregivers reported a visit to an emergency department in the 12 months prior to the survey. Among the types/subtypes represented, recessive dystrophic epidermolysis bullosa results in the greatest wound burden, with approximately 60% of patients and caregivers reporting wounds covering > 30% of total body area. Wound care is time consuming and commonly requires significant caregiver assistance. Therapeutic options are urgently needed and reducing the number and severity of wounds was generally ranked as the most important treatment factor.

conclusionsSurvey responses demonstrate that epidermolysis bullosa places a considerable burden on patients, their caregivers, and their families. The limitations caused by epidermolysis bullosa mean that both patients and caregivers must make difficult choices and compromises regarding education, career, and home life. Finally, survey results indicate that epidermolysis bullosa negatively impacts quality of life and causes financial burden to patients and their families.

Indexed as

AdolescentAdultAgedCaregiversCost of IllnessEpidermolysis BullosaFemaleHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesUnited StatesYoung AdultCaregiversDisease burdenEpidermolysis bullosaFinancial burdenManagementPatientsQuality of lifeSurveyWound care

Identifiers

PMID31900176
PMCPMC6942340
OpenAlexW2998937058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.